Back to Search
DR. JOHN BRIAN CATALANO MD
MD
Orthopaedic Surgery Physician
NPI: 1659446607IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
MA59003(NJ)
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1988
Research & Publications (20)
Substituted tetrahydrocarbazoles with potent activity against human papillomaviruses.
PMID 19457669·Bioorg Med Chem Lett·2009
7-preclinical
Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome.
PMID 19371627·Toxicol Appl Pharmacol·2009
8-other
Nanoscale size effects on uranium(VI) adsorption to hematite.
PMID 19350906·Environ Sci Technol·2009
8-other
Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.
PMID 19640718·Bioorg Med Chem Lett·2009
8-other
Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.
PMID 18474089·BMC Cancer·2008
8-other
Bioflora probiotic in immunomodulation and prophylaxis of intestinal bacterial translocation in rats.
PMID 18320321·Dig Dis Sci·2008
7-preclinical
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma.
PMID 18362366·J Clin Oncol·2008
3-trial
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
PMID 18932253·Cancer·2008
3-trial
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
PMID 18662969·J Clin Oncol·2008
3-trial
Hexavalent chromium exposures and exposure-control technologies in American enterprise: results of a NIOSH field research study.
PMID 17577750·J Occup Environ Hyg·2007
8-other
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors.
PMID 17157021·Bioorg Med Chem Lett·2007
8-other
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
PMID 16376075·Bioorg Med Chem Lett·2006
4-observational
Inner-sphere adsorption geometry of Se(IV) at the hematite (100)-water interface.
PMID 16386265·J Colloid Interface Sci·2006
8-other
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.
PMID 16556892·Blood·2006
3-trial
Termination and water adsorption at the alpha-Al2O3 (012)-aqueous solution interface.
PMID 16649780·Langmuir·2006
8-other
Changes in uranium speciation through a depth sequence of contaminated Hanford sediments.
PMID 16683586·Environ Sci Technol·2006
8-other
A Mediator-responsive form of metazoan RNA polymerase II.
PMID 16769904·Proc Natl Acad Sci U S A·2006
7-preclinical
On the use of CCD area detectors for high-resolution specular X-ray reflectivity.
PMID 16799220·J Synchrotron Radiat·2006
6-review
Surface complexation studied via combined grazing-incidence EXAFS and surface diffraction: arsenate on hematite (0001) and (10-12).
PMID 16142422·Anal Bioanal Chem·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 352 S DELSEA DR STE C
VINELAND, NJ 08360 - Phone
- (856) 690-1616
Quick Facts
- NPI
- 1659446607
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile